Adipocytokine regulatory pathways in adipose tissue

Adipocytokine regulatory pathways in adipose tissue represent a complex network of signaling cascades mediated by bioactive molecules secreted by adipocytes, known as adipokines (e.g., leptin, adiponectin, and resistin). These pathways are fundamental to maintaining systemic energy homeostasis by integrating signals between adipose tissue and metabolic organs such as the liver, skeletal muscle, and the hypothalamus (PubMed: 16456578). In a physiological state, adiponectin promotes insulin sensitivity and fatty acid oxidation via AMPK activation, while leptin regulates appetite and energy expenditure (StatPearls: Adipocytokines). However, in the context of obesity, these pathways become dysregulated, leading to a decrease in anti-inflammatory adipokines and an increase in pro-inflammatory cytokines like TNF-alpha and IL-6, which drive chronic low-grade inflammation and insulin resistance (KEGG: map04920). This dysregulation is a primary driver of metabolic syndrome, type 2 diabetes, and nonalcoholic fatty liver disease. While the pathway itself is a biological process rather than a single molecular target, its individual components—such as the Adiponectin receptors (AdipoR1/R2) and PPAR-gamma—are major focuses for therapeutic intervention. Drugs like thiazolidinediones (e.g., pioglitazone) target these pathways to restore metabolic balance, though they must be managed carefully due to side effects like fluid retention (PubMed: 17213673).

Other names

Adipocytokine signaling pathwayAdipokine signalingAdipose tissue endocrine functionKEGG: hsa04920

Modulation of specific nodes within the pathway, such as activation of Peroxisome proliferator-activated receptor gamma (PPAR-gamma) or Adenosine monophosphate-activated protein kinase (AMPK), to improve insulin sensitivity and reduce pro-inflammatory cytokine production.